SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-21-033123
Filing Date
2021-09-30
Accepted
2021-09-30 17:12:49
Documents
4
Period of Report
2021-11-23

Document Format Files

Seq Description Document Type Size
1 PRE 14A ny20000854x1_pre14a.htm PRE 14A 609705
2 ny20000854x1_pc01x1.jpg GRAPHIC 708012
3 ny20000854x1_pc02x1.jpg GRAPHIC 421889
4 sig_yniihara.jpg GRAPHIC 21048
  Complete submission text file 0001140361-21-033123.txt   2195350
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35527 | Film No.: 211295786
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences